Physical and functional interaction between WT1 and p53 proteins.

Shyamala Maheswaran(Massachusetts General Hospital), Daniel A. Haber(Howard Hughes Medical Institute), Soon‐Jung Park(The Wistar Institute), David E. Hill(Harvard University), Jennifer Morris(Massachusetts General Hospital), Frank J. Rauscher(The Wistar Institute), Amy Bernard(The Wistar Institute)
Proceedings of the National Academy of Sciences
June 1, 1993
10.1073/pnas.90.11.5100
Cited by 307

Related Papers

Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
|Cell|2010|2.8k
Systematic identification of genomic markers of drug sensitivity in cancer cells
|Nature|2012|2.6k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k